Chief Executive Officer, SaNOtize

Dr. Regev is a biotech executive experienced in launching pharmaceutical enterprises. With her prior work experience, business skills and academic qualifications, Dr. Regev brings a wealth of expertise to her endeavors.

Dr. Regev co-founded SaNOtize in 2017 and has served as its Chief Executive Officer since incorporation. As CEO, she oversees all operations and business activities as well as all aspects of research from bench to clinical trials, regulatory affairs and intellectual property development. She has been leading SaNOtize since incorporation and, together with her team, has achieved significant progress in the past 3 years. She led SaNOtize’s licensing deals and raised over $8M in equity and non-dilutional funding.

Dr. Regev has worked in the field of nitric oxide for the past 12 years, first at Nitric Solutions where she served as Director of R&D, and then later from 2012-2017 as the co-founder and Chief Scientific Officer for Bovicor.

Dr. Regev received her Ph.D. in Biochemistry from the Hebrew University of Jerusalem in 2004 and has 30 years of research experience with analytical chemistry, redox reactions, antioxidants and different aspects of microbiology.